| Active ingredient (INN) | Docetaxel |
|---|---|
| Brand names | Docetaxel Accord, Docetaxel Glenmark |
| ATC level 5 | L01CD02 |
| ATC level 4 | L01CD |
| Therapeutic category | Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Accord Healthcare Pty Ltd, HIKMA PHARMACEUTICALS USA INC., Pfizer Australia Pty Ltd, Sandoz Pty Ltd +4 more |
| Registrations on file | 29 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Docetaxel Accord | 160 mg | — | 🇦🇺 AU | Accord Healthcare Pty Ltd | Active |
| Docetaxel | 20mg/mL | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Dbl Docetaxel Concentrated | 80mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| Dbl Docetaxel Concentrated | 20mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| Dbl Docetaxel Concentrated | 160mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| Sandoz | 20mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Sandoz | 80mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| An | 20mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Gn | 80mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| An | 80mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Gn | 20mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| KABI docetaxel anhydrous | 80 mg | — | 🇦🇺 AU | Fresenius Kabi Australia Pty Ltd | Active |
| KABI docetaxel anhydrous | 20 mg | — | 🇦🇺 AU | Fresenius Kabi Australia Pty Ltd | Active |
| KABI docetaxel anhydrous | 160 mg | — | 🇦🇺 AU | Fresenius Kabi Australia Pty Ltd | Active |
| Docetaxel Accord | 80 mg | — | 🇦🇺 AU | Accord Healthcare Pty Ltd | Active |